期刊文献+

白介素2、华蟾素加强狂犬病疫苗免疫的实验研究 被引量:1

INTERLEUKIN-2 AND CINOBUFAGIN AS ADJUVENT TO INCREASE THE IMMUNE RSPONSE TO INACTIVATED RABIES VIRUS VACCINE
下载PDF
导出
摘要 目的 :探讨白细胞介素 - 2 (IL - 2 )、华蟾素能否作为佐剂增强狂犬病毒灭活疫苗在小鼠体内的免疫应答。方法 :将昆明种小鼠 12 0只随机分成 3组 ,分别注射IL - 2加狂犬病毒灭活疫苗、华蟾素加狂犬病毒灭活疫苗、狂犬病毒灭活疫苗 (对照组 ) ,检测不同时期的中和抗体效价。结果 :① 3组免疫后的GMT :12日时分别为 10 0、70 .71、5 0 (P <0 .0 5 ) ;17、2 2日时分别为 14 1.4 2、10 0、10 0 (P >0 .0 5 ) ;2 7日时分别为 14 1.4 2、10 0、70 .71(P >0 .0 5 ) ;32日时分别为 10 0、10 0、5 0 (P >0 .0 5 )。②IL - 2组第 7日出现抗体 ,而华蟾素组和对照组均在第 12日时开始出现。结论 :在白细胞介素 2的作用下 ,抗体产生的时间提前 ,抗体效价提高 ,华蟾素有此效应 。 Objective: To determine whether interleuki n-2(IL-2)and Cinobufagin could be adjuvents to increase virus-neutralizing antibody of mouse induced by inactivated rabies virus vaccine. Methods: 120 KunMing variant mice were divided randomly into three groups. They were immunized by the inactivated rabies virus vaccine with IL-2,or with Cinobufagin, or vaccine only(control group), respectiv ely. Virus-neutralizing antibodies were detected at the 7th,12th,17th,22nd and 3 2nd day after vaccination. Results:①The GMT of each group was 100,70.71,50and(P <0.05)at the 12th day, respectively; 141.42,100and100 (P >0.05) at the 17th and 2 2ndday,respectively;141.42and100,70.71(P>0.05)at the 27n d day, respectively;100,100 and50 (P>0.05) at the 32nd day ,respectively;②Virus-neutralizing antibody of the group with I L-2 appeared at the 7th day, but that of the group with Cinobufagin and control group appeared at the 12th day. Conclusions: Virus-neutralizing antibodies in th e group with IL-2 had appeared 5 days earlier than in the control group and anti body titer had raised much higher. It seems Cinobufagin also had this effect but there was no significant difference.
出处 《泸州医学院学报》 2003年第2期113-116,共4页 Journal of Luzhou Medical College
关键词 狂犬病 疫苗 佐剂 白细胞介素-2 华蟾素 Inactivated rabies virus vaccine Interleukin-2 Cinobufa gin Neutralizing antibody
  • 相关文献

参考文献5

二级参考文献7

共引文献6

同被引文献20

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部